BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masomian M, Ahmad Z, Gew LT, Poh CL. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel) 2020;8:E132. [PMID: 32192117 DOI: 10.3390/vaccines8010132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Principi N, Esposito S. Pneumococcal Disease Prevention: Are We on the Right Track? Vaccines (Basel) 2021;9:305. [PMID: 33804822 DOI: 10.3390/vaccines9040305] [Reference Citation Analysis]
2 Lane JR, Tata M, Briles DE, Orihuela CJ. A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae. Front Cell Infect Microbiol 2022;12:826264. [DOI: 10.3389/fcimb.2022.826264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Root-Bernstein R. Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death. Vaccines (Basel) 2020;8:E559. [PMID: 32987794 DOI: 10.3390/vaccines8040559] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
4 Scott NR, Mann B, Tuomanen EI, Orihuela CJ. Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines. Vaccines (Basel) 2021;9:209. [PMID: 33801372 DOI: 10.3390/vaccines9030209] [Reference Citation Analysis]
5 Scelfo C, Menzella F, Fontana M, Ghidoni G, Galeone C, Facciolongo NC. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines (Basel) 2021;9:420. [PMID: 33922273 DOI: 10.3390/vaccines9050420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Marra LP, Sartori AL, Martinez-silveira MS, Toscano CM, Andrade AL. Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review. Value in Health 2022. [DOI: 10.1016/j.jval.2021.12.012] [Reference Citation Analysis]
7 Mateu Ferrando R, Lay L, Polito L. Gold nanoparticle-based platforms for vaccine development. Drug Discov Today Technol 2020;38:57-67. [PMID: 34895641 DOI: 10.1016/j.ddtec.2021.02.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Perdrizet J, Farkouh RA, Horn EK, Hayford K, Sings HL, Wasserman MD. The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Rev Vaccines 2022;:1-13. [PMID: 35191368 DOI: 10.1080/14760584.2022.2040989] [Reference Citation Analysis]
9 Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. BMJ 2021;372:n188. [PMID: 33619170 DOI: 10.1136/bmj.n188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Morelli L, Lay L, Santana-Mederos D, Valdes-Balbin Y, Verez Bencomo V, van Diepen A, Hokke CH, Chiodo F, Compostella F. Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A. ACS Chem Biol 2021;16:1671-9. [PMID: 34469105 DOI: 10.1021/acschembio.1c00347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Singh M, Sori H, Ahuja R, Meena J, Sehgal D, Panda AK. Effect of N-terminal poly histidine-tag on immunogenicity of Streptococcus pneumoniae surface protein SP0845. International Journal of Biological Macromolecules 2020;163:1240-8. [DOI: 10.1016/j.ijbiomac.2020.07.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Yan Z, Cui Y, Huang X, Lei S, Zhou W, Tong W, Chen W, Shen M, Wu K, Jiang Y. Molecular Characterization Based on Whole-Genome Sequencing of Streptococcus pneumoniae in Children Living in Southwest China During 2017-2019. Front Cell Infect Microbiol 2021;11:726740. [PMID: 34796125 DOI: 10.3389/fcimb.2021.726740] [Reference Citation Analysis]
13 Skurnik M. Can Bacteriophages Replace Antibiotics? Antibiotics 2022;11:575. [DOI: 10.3390/antibiotics11050575] [Reference Citation Analysis]
14 Basu N, Ghosh R. Recent chemical syntheses of bacteria related oligosaccharides using modern expeditious approaches. Carbohydr Res 2021;507:108295. [PMID: 34271477 DOI: 10.1016/j.carres.2021.108295] [Reference Citation Analysis]
15 Grego EA, Siddoway AC, Uz M, Liu L, Christiansen JC, Ross KA, Kelly SM, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles. Curr Top Microbiol Immunol 2021;433:29-76. [PMID: 33165869 DOI: 10.1007/82_2020_226] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sempere J, Llamosí M, Del Río Menéndez I, López Ruiz B, Domenech M, González-Camacho F. Pneumococcal Choline-Binding Proteins Involved in Virulence as Vaccine Candidates. Vaccines (Basel) 2021;9:181. [PMID: 33672701 DOI: 10.3390/vaccines9020181] [Reference Citation Analysis]
17 Hu T, Done N, Petigara T, Mohanty S, Song Y, Liu Q, Lemus-wirtz E, Signorovitch J, Sarpong E, Weiss T. Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07275-9] [Reference Citation Analysis]
18 Wójcik-Bojek U, Różalska B, Sadowska B. Staphylococcus aureus-A Known Opponent against Host Defense Mechanisms and Vaccine Development-Do We Still Have a Chance to Win? Int J Mol Sci 2022;23:948. [PMID: 35055134 DOI: 10.3390/ijms23020948] [Reference Citation Analysis]
19 Lannes-Costa PS, de Oliveira JSS, da Silva Santos G, Nagao PE. A current review of pathogenicity determinants of Streptococcus sp. J Appl Microbiol 2021. [PMID: 33772968 DOI: 10.1111/jam.15090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tobuse AJ, Ang CW, Yeong KY. Modern vaccine development via reverse vaccinology to combat antimicrobial resistance. Life Sciences 2022;302:120660. [DOI: 10.1016/j.lfs.2022.120660] [Reference Citation Analysis]
21 Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 2021;18:38. [PMID: 34627326 DOI: 10.1186/s12979-021-00249-6] [Reference Citation Analysis]
22 Pereira JM, Xu S, Leong JM, Sousa S. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Front Immunol 2022;13:878244. [DOI: 10.3389/fimmu.2022.878244] [Reference Citation Analysis]
23 Oliveira GS, Oliveira MLS, Miyaji EN, Rodrigues TC. Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines (Basel) 2021;9:1338. [PMID: 34835269 DOI: 10.3390/vaccines9111338] [Reference Citation Analysis]
24 Froneman C, Kelleher P, José RJ. Pneumococcal Vaccination in Immunocompromised Hosts: An Update. Vaccines (Basel) 2021;9:536. [PMID: 34063785 DOI: 10.3390/vaccines9060536] [Reference Citation Analysis]
25 Esposito S, Dal Canto G, Caramia MR, Fainardi V, Pisi G, Principi N. Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age. Expert Rev Anti Infect Ther 2021;:1-7. [PMID: 33971782 DOI: 10.1080/14787210.2021.1927710] [Reference Citation Analysis]
26 Koufoglou E, Kourlaba G, Michos A. Effect of prophylactic administration of antipyretics on the immune response to pneumococcal conjugate vaccines in children: a systematic review. Pneumonia (Nathan) 2021;13:7. [PMID: 33894782 DOI: 10.1186/s41479-021-00085-8] [Reference Citation Analysis]
27 Deng JZ, Lancaster C, Winters MA, Phillips KM, Zhuang P, Ha S. Multi-attribute characterization of pneumococcal conjugate vaccine by Size-exclusion chromatography coupled with UV-MALS-RI detections. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.01.042] [Reference Citation Analysis]
28 Corsini B, Aguinagalde L, Ruiz S, Domenech M, Yuste J. Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System. Vaccines (Basel) 2021;9:186. [PMID: 33672306 DOI: 10.3390/vaccines9020186] [Reference Citation Analysis]
29 Redin A, Ciruela P, de Sevilla MF, Gomez-Bertomeu F, Gonzalez-Peris S, Benitez MA, Trujillo G, Diaz A, Jou E, Izquierdo C, Perez-Moreno MO, Moraga-Llop F, Olsina M, Vinado B, Sanfeliu E, Garcia A, Gonzalez-di Lauro S, Garcia-Garcia JJ, Dominguez A, Sa-Leao R, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Microbiol Spectr 2021;9:e0115021. [PMID: 34878302 DOI: 10.1128/Spectrum.01150-21] [Reference Citation Analysis]
30 Dietl B, Henares D, Boix-Palop L, Muñoz-Almagro C, Garau J, Calbo E. Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome. Front Med (Lausanne) 2021;8:650271. [PMID: 33996857 DOI: 10.3389/fmed.2021.650271] [Reference Citation Analysis]
31 Talat A, Khan AU. Vaccines against antimicrobial resistance: a promising escape route for multidrug resistance. Pharm Pat Anal 2021;10:83-98. [PMID: 33829866 DOI: 10.4155/ppa-2020-0022] [Reference Citation Analysis]
32 Sundaresh B, Xu S, Noonan B, Mansour MK, Leong JM, van Opijnen T. Host-informed therapies for the treatment of pneumococcal pneumonia. Trends Mol Med 2021:S1471-4914(21)00189-1. [PMID: 34376327 DOI: 10.1016/j.molmed.2021.07.008] [Reference Citation Analysis]
33 Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M, Regueira M, Lara CS, Corso A; Argentina Spn Working Group. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 2021:S0264-410X(21)01616-9. [PMID: 34920903 DOI: 10.1016/j.vaccine.2021.12.008] [Reference Citation Analysis]
34 Martín-Galiano AJ, García E. Streptococcus pneumoniae: a Plethora of Temperate Bacteriophages With a Role in Host Genome Rearrangement. Front Cell Infect Microbiol 2021;11:775402. [PMID: 34869076 DOI: 10.3389/fcimb.2021.775402] [Reference Citation Analysis]